loading

なぜKintara Therapeutics Inc(KTRA)の株価が下がっていますか?

2024-05-14 の取引セッション中に、Kintara Therapeutics Inc (KTRA) 株の 7.25% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-10-31:

Kintara Therapeutics Stock (KTRA) dropped by 79.68% from $3.76 to $0.764 in the trading on Tuesday October 31, 2023. The reason why KTRA stock down today is due to VAL-083 failure. The company has announced that their drug VAL-083 did not outperform existing treatments for glioblastoma, a severe brain cancer. Kintara is discontinuing the development of VAL-083 and shifting their focus to REM-001, a localized tumor treatment. Kintara will also explore strategic options to maximize shareholder value.

$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
大文字化:     |  ボリューム (24 時間):